Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.265 CAD | +3.92% | -3.64% | +1.92% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 43.91 | 27.31 | 23.41 | 84.39 | 68.47 | 51.17 |
Enterprise Value (EV) 1 | 69.43 | 59 | 59.42 | 97.91 | 91.1 | 72.19 |
P/E ratio | -22.7 x | -12.4 x | -3.81 x | -8.65 x | -7.47 x | -72.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -40.9 x | -30.6 x | -73.9 x | -68.1 x | -54.7 x | -37.8 x |
EV / FCF | -29.7 x | -14.1 x | -13.6 x | -20.8 x | -16 x | 101 x |
FCF Yield | -3.36% | -7.1% | -7.38% | -4.82% | -6.26% | 0.99% |
Price to Book | 1.64 x | 0.98 x | 0.98 x | 1.86 x | 1.87 x | 1.33 x |
Nbr of stocks (in thousands) | 105,804 | 111,458 | 123,198 | 185,464 | 190,187 | 196,809 |
Reference price 2 | 0.4150 | 0.2450 | 0.1900 | 0.4550 | 0.3600 | 0.2600 |
Announcement Date | 3/20/19 | 3/18/20 | 3/29/21 | 3/30/22 | 4/24/23 | 4/24/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -1.696 | -1.93 | -0.8036 | -1.437 | -1.667 | -1.909 |
EBIT 1 | -1.746 | -1.976 | -0.8828 | -1.482 | -1.76 | -2.022 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -1.842 | -2.06 | -5.845 | -8.242 | -8.97 | -0.8691 |
Net income 1 | -1.93 | -2.156 | -5.913 | -8.83 | -9.101 | -0.6986 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.0183 | -0.0198 | -0.0499 | -0.0526 | -0.0482 | -0.003586 |
Free Cash Flow 1 | -2.336 | -4.191 | -4.382 | -4.716 | -5.703 | 0.7169 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/20/19 | 3/18/20 | 3/29/21 | 3/30/22 | 4/24/23 | 4/24/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 25.5 | 31.7 | 36 | 13.5 | 22.6 | 21 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -15.05 x | -16.42 x | -44.81 x | -9.408 x | -13.58 x | -11.01 x |
Free Cash Flow 1 | -2.34 | -4.19 | -4.38 | -4.72 | -5.7 | 0.72 |
ROE (net income / shareholders' equity) | -7.17% | -7.92% | -22.9% | -25.5% | -22.9% | -1.86% |
ROA (Net income/ Total Assets) | -1.9% | -1.99% | -0.86% | -1.4% | -1.64% | -1.89% |
Assets 1 | 101.8 | 108.2 | 691.4 | 632.3 | 556.2 | 36.88 |
Book Value Per Share 2 | 0.2500 | 0.2500 | 0.1900 | 0.2400 | 0.1900 | 0.2000 |
Cash Flow per Share 2 | 0.0200 | 0 | 0.0100 | 0.0300 | 0.0200 | 0.0200 |
Capex 1 | 2.32 | 2.32 | 0.72 | 0.61 | 0.53 | 0.25 |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/20/19 | 3/18/20 | 3/29/21 | 3/30/22 | 4/24/23 | 4/24/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.92% | 39.28M | |
-14.40% | 143B | |
-6.66% | 117B | |
-0.55% | 71.07B | |
+6.69% | 50.97B | |
+13.30% | 48.38B | |
+34.12% | 39.93B | |
+22.92% | 26.1B | |
+32.58% | 21.36B | |
+58.44% | 18.57B |
- Stock Market
- Equities
- DAN Stock
- Financials Arianne Phosphate Inc.